z-logo
open-access-imgOpen Access
The Effect of Thymosin beta4 on the Survival of Autologous Fat Grafting: A Preliminary Study
Author(s) -
Yaping Qu,
Qian Wang,
Su Fu,
Xiaoshuang Guo,
Jie Luan,
Dali Mu
Publication year - 2020
Publication title -
aesthetic surgery journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.528
H-Index - 58
eISSN - 1527-330X
pISSN - 1090-820X
DOI - 10.1093/asj/sjaa062
Subject(s) - medicine , grafting , surgery , thymosin , chemistry , organic chemistry , polymer
Background Autologous fat grafting is a common procedure to improve tissue deficiencies. However, the survival rate of fat grafting is unpredictable. Thymosin beta 4 (Tß4), a multifunctional peptide containing 43 amino acids, is effective in angiogenesis, inhibiting apoptosis and inflammation. Objectives The authors initially investigated the potential effect of Tß4 in fat grafting. Methods Adipose tissue premixed exogenous Tß4 were transplanted into rabbit ears. Rabbits were randomly assigned to 3 groups: group A, 5 μg/mL Tß4; group B, 10 μg/mL Tß4; and group C, phosphate-buffered saline buffer as a blank control. The fat grafts were subjected to magnetic resonance imaging at 2, 4, and 12 weeks in vivo. Each harvested graft was analyzed at 3 time points after transplantation. Results The fat grafts in the Tß4-treated groups showed better volume and weight retention, greater adipose tissue integrity, adipocyte viability, and angiogenesis. The results of dynamic contrast-enhanced magnetic resonance imaging also showed that the experimental groups increased microcirculation perfusion of the grafts. Conclusions The study proved that Tß4 could improve adipose tissue survival and neovascularization. It may be useful for fat grafting as a potential protective reagent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom